Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02266914 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Elastography of Cardiac Transplant Rejection
A NA study, sponsored by Ohio State University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02266914: Clinical Trial NA study, sponsored by Ohio State University.
NCT02266914 is a NA study that was terminated before completion, run by Ohio State University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02266914, a NA study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Magnetic Resonance Elastography (MRE) for cardiac transplant patients.
Primary Outcome
MRE scans will be performed within 24-48 hours of standard of care cardiac biopsies for patients who have undergone cardiac transplant at The Ohio State University Ross Heart Hospital. Stiffness results from the MRE will be compared to histopathology from the cardiac biopsy to determine if the completely non-invasive MRE can successfully predict transplant rejection.
Interventions
- DEVICE Magnetic Resonance Elastography driver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-01-27 |
| Est. Completion | 2017-12-01 |
| Phase | NA |
Why NCT02266914 stopped before completion
NCT02266914 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Elastography driver is the first listed.
NCT02266914 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02266914 about?
NCT02266914 is a clinical study titled "Magnetic Resonance Elastography of Cardiac Transplant Rejection". Magnetic Resonance Elastography (MRE) for cardiac transplant patients.
What is the current status of trial NCT02266914?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2014-01-27. Estimated completion is 2017-12-01.
What interventions are being tested in trial NCT02266914?
The interventions under investigation include: Magnetic Resonance Elastography driver (DEVICE).
Who is sponsoring clinical trial NCT02266914?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02266914's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI